Viewing nowArotor Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201707527 · Approved 2017.10.19 · Insurance code 648603580
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps lower the risk of cardiovascular disease. It particularly reduces the risk of myocardial infarction, stroke, and angina in adults who are over the age of 55, or have risk factors such as smoking, hypertension, low HDL cholesterol levels, or a family history of early coronary heart disease. It also reduces the risk of myocardial infarction and stroke in patients with type 2 diabetes who have specific risk factors. In patients with clinical evidence of coronary artery disease, it reduces the risk of non-fatal myocardial infarction, stroke, and hospitalization for congestive heart failure. In the treatment of hyperlipidemia, it acts as an adjunct to diet by improving cholesterol and triglyceride levels, and effectively lowers lipid levels in patients with familial hypercholesterolemia, contributing to vascular health. Additionally, it is used to reduce cardiovascular disease risk by lowering lipid levels in some pediatric patients aged 10 to 17 years with familial hypercholesterolemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ∼ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol levels be used when initiating treatment and evaluating treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ∼ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ∼ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle abnormalities, so if severe muscle pain or weakness occurs, or if creatine kinase levels significantly increase, it should be discontinued immediately. Patients with impaired liver function or liver disease should not use this medication, and if symptoms of liver dysfunction arise, they should consult a doctor immediately. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Children, especially those under 10 years of age, should not use this medication, and children aged 10 to 17 years should use it with caution. Individuals with a history of alcohol abuse or liver disease, patients with impaired kidney function, and individuals with hypothyroidism should consult a doctor before taking this medication. There may be interactions with other medications, so patients should inform their doctor or pharmacist of any medications they are currently taking. Particular caution is required when taken with certain antibiotics, antifungals, antivirals, immunosuppressants, and some medications for hyperlipidemia. During the use of this medication, report symptoms such as muscle pain, fatigue, or fever to healthcare personnel immediately, and it is important to regularly monitor liver function and muscle status through blood tests. This medication should be avoided with grapefruit juice, as it may increase blood concentration and the risk of side effects, so avoid consuming grapefruit juice. Keep out of reach of children and store in the original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to store at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the drug's efficacy and safety.
White round film-coated tablet
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.